Related Experiment Video
Updated: Aug 6, 2026
07:24
Repression of Multiple Myeloma Cell Growth In Vivo by Single-wall Carbon Nanotube (SWCNT)-delivered MALAT1 Antisense Oligos
Published on: December 13, 2018
Long non-coding RNAs: a new hope for the cervical cancer staging
Aahelee Ghosh1, Anupriya Bandyopadhyay2, Aparna Mukhopadhyay3
1Department of Biotechnology, St. Xavier's College (Autonomous), 30, Mother Teresa Sarani, West Bengal, 700016, Kolkata, India.
Molecular Biology Reports
|July 18, 2026
Summary
Long non-coding RNAs (lncRNAs) show promise as biomarkers for cervical cancer (CC) detection and staging. Further research into these epigenetic regulators could lead to new therapeutic targets for CC.
Area of Science:
- Oncology
- Epigenetics
- Molecular Biology
Background:
- Cervical cancer (CC) remains a significant global health concern, primarily caused by Human Papillomavirus (HPV) infection.
- CC is classified into FIGO stages based on tumor characteristics, with early stages being curable and late stages often fatal.
- Epigenetic biomarkers, particularly long non-coding RNAs (lncRNAs), are gaining attention for their roles in cancer development and progression.
Purpose of the Study:
- To review the known roles of lncRNAs as prognostic biomarkers in cervical cancer.
- To identify uniquely upregulated lncRNAs at various stages of CC using Gene Expression Omnibus (GEO) data.
- To highlight the potential of lncRNAs as diagnostic and therapeutic targets for CC.
Main Methods:
- Literature review of lncRNAs in cervical cancer prognosis.
- Bioinformatic analysis of Gene Expression Omnibus (GEO) datasets to identify differentially expressed lncRNAs in CC.
- Discussion of the regulatory mechanisms of lncRNAs in cancer epigenetics.
Main Results:
- lncRNAs exhibit stage-specific differential expression in CC, suggesting their utility in cancer staging.
- lncRNAs regulate gene expression and epigenetic modifications, influencing CC development and progression.
- Several lncRNAs were identified as uniquely upregulated in various stages of CC through GEO data analysis.
Conclusions:
- lncRNAs represent promising epigenetic biomarkers for the early detection and staging of cervical cancer.
- Understanding the functional roles of lncRNAs in CC could pave the way for novel therapeutic strategies.
- Further exploration of lncRNAs may lead to targeted treatments for improving cervical cancer outcomes.
Related Concept Videos
02:39lncRNA - Long Non-coding RNAs
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA (lncRNA)...
01:03Rous Sarcoma Virus (RSV) and Cancer
Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
01:03Rous Sarcoma Virus (RSV) and Cancer
Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
01:20Types of RNA
Three main types of RNA are involved in protein synthesis: messenger RNA (mRNA), transfer RNA (tRNA), and ribosomal RNA (rRNA). These RNAs perform diverse functions and can be broadly classified as protein-coding or non-coding RNA. Non-coding RNAs play important roles in regulating gene expression in response to developmental and environmental changes. Non-coding RNAs in prokaryotes can be manipulated to develop more effective antibacterial drugs for human or animal use.
RNA Performs Diverse...
RNA Performs Diverse...
02:55The Nucleolus
The nucleolus is the most prominent substructure of the nucleus. When it was first discovered, it was considered to be an isolated organelle that forms fibrils and granules. In 1931, the relationship between the nucleolus and chromosomes was first described by Heitz. He observed that the appearance and size of nucleolus varies depending on the stage of the cell cycle. He also noticed constricted regions on different chromosomes clustered together at definite cell cycle stages. These regions,...
02:28Leaky Scanning
During most eukaryotic translation processes, the small 40S ribosome subunit scans an mRNA from its 5' end until it encounters the first start AUG codon. The large 60S ribosomal subunit then joins the smaller one to initiate protein synthesis. The location of the translation initiation is largely determined by the nucleotides near the start codon as there may be multiple translation initiation sites present on the mRNA. Marilyn Kozak discovered that the sequence RCCAUGG (where R stands for...